Epigenomics AG 0QXH.L Stock
Epigenomics AG Price Chart
Epigenomics AG 0QXH.L Financial and Trading Overview
| Epigenomics AG stock price | 0.76 EUR |
| Previous Close | 0 EUR |
| Open | 0 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 0 - 0 EUR |
| 52 Week Range | 0 - 0 EUR |
| Volume | 0 EUR |
| Avg. Volume | N/A |
| Market Cap | 126.44K EUR |
| Beta (5Y Monthly) | 1.047892 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.283 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0QXH.L Valuation Measures
| Enterprise Value | -346702 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.25086707 |
| Price/Book (mrq) | 0.3357183 |
| Enterprise Value/Revenue | -0.688 |
| Enterprise Value/EBITDA | 0.024 |
Trading Information
Epigenomics AG Stock Price History
| Beta (5Y Monthly) | 1.047892 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0 EUR |
| 52 Week Low | 0 EUR |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
0QXH.L Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | 24.01M |
| Float | 2.13M |
| Short Ratio | N/A |
| % Held by Insiders | 33.12% |
| % Held by Institutions | 4.86% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3187.50% |
| Gross Margin | 73.80% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -59.91% |
| Return on Equity (ttm) | -126.60% |
Income Statement
| Revenue (ttm) | 504K EUR |
| Revenue Per Share (ttm) | 0.12 EUR |
| Quarterly Revenue Growth (yoy) | 16.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -14507000 EUR |
| Net Income Avi to Common (ttm) | -14958000 EUR |
| Diluted EPS (ttm) | -0.283 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.89M EUR |
| Total Cash Per Share (mrq) | 1.61 EUR |
| Total Debt (mrq) | 439K EUR |
| Total Debt/Equity (mrq) | 9.66 EUR |
| Current Ratio (mrq) | 1.212 |
| Book Value Per Share (mrq) | 1.065 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12032000 EUR |
| Levered Free Cash Flow (ttm) | -5655500 EUR |
Profile of Epigenomics AG
| Country | United Kingdom |
| State | N/A |
| City | Berlin |
| Address | Geneststrasse 5 |
| ZIP | 10829 |
| Phone | 49 30 243 450 |
| Website | https://www.epigenomics.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 26 |
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. The company was founded in 1998 and is headquartered in Berlin, Germany.
Q&A For Epigenomics AG Stock
What is a current 0QXH.L stock price?
Epigenomics AG 0QXH.L stock price today per share is 0.76 EUR.
How to purchase Epigenomics AG stock?
You can buy 0QXH.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Epigenomics AG?
The stock symbol or ticker of Epigenomics AG is 0QXH.L.
How many shares does Epigenomics AG have in circulation?
The max supply of Epigenomics AG shares is 353.63K.
What is Epigenomics AG Price to Earnings Ratio (PE Ratio)?
Epigenomics AG PE Ratio is now.
What was Epigenomics AG earnings per share over the trailing 12 months (TTM)?
Epigenomics AG EPS is -0.283 EUR over the trailing 12 months.